In June 2017, the European Federation of Pharmaceutical Industries and Associations (EFPIA) with support from the ABPI in the UK, launched #WeWontRest.
The new campaign focuses on the passion, commitment and dedication of individuals, teams and companies in the pharmaceutical industry to discovering and developing new medicines for patients. We’re telling our industry’s innovation story and using #WeWontRest to start the public discussion on the value of innovation, the value of medicines and the future of healthcare in Europe.
The #WeWontRest campaign is being supported by EFPIA's member associations and companies in 27 European countries. Individuals and teams at all levels of the pharmaceutical industry across Europe making pledges: from General Managers to front-line scientists. The UK is proud to support the campaign and will be celebrating a summer of science throughout June, July and August.
#WeWontRest until we manage to deliver solutions that make blood cancer a manageable of even curable condition.
#WeWontRest until we find ways to modify the course of Alzheimer's.
#WeWontRest until our regulatory work, in partnership with others, accelerates patient access to innovative medicines.
#WeWontRest until a cure for people living with Type 1 Diabetes is available.
#WeWontRest until cycling through treatments is no longer the norm for people with rheumatoid arthritis.
#WeWontRest until Multiple Sclerosis is no longer a life sentence.
#WeWontRest until patients have new treatment options to fight the world's deadliest diseases.
#WeWontRest until we solve the Alzheimer's puzzle.